Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 1.000 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.491 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.480 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.474 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.471 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.469 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.469 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.464 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.463 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.462 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.462 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.461 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.460 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.458 | |
4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.458 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.456 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.455 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.454 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.453 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.450 | |
2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.450 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.450 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.450 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.449 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.449 | |
3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.448 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.448 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.448 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.445 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.445 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.445 | |
5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.445 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.444 | |
4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.444 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.443 | |
4kzo | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.443 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.443 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.442 | |
2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.440 |